GS
The Goldman Sachs Group, Inc.
GS has the edge over HTH overall, supported by stronger fundamentals and stronger valuation.
HTH
Hilltop Holdings Inc.
HTH has slightly lower modeled downside risk, despite its lower overall score.
GS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
GS's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like GS.
HTH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
HTH's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like HTH.
GS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.6x | $528 | -42% |
| Current | 13x | $914 | — |
| Forward | 13x | $914 | — |
| Fair | 14x | $940 | +2.9% |
| Expensive | 17x | $1,214 | +33% |
Historical ranges are pointers, not guarantees.
GS has the edge over HTH in the historical PE scenario, which offers more potential upside but is not a forecast.
HTH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.5x | $15.72 | -56% |
| Fair | 14x | $34.01 | -5.8% |
| Current | 15x | $36.10 | — |
| Forward | 16x | $36.10 | — |
| Expensive | 18x | $43.63 | +21% |
Historical ranges are pointers, not guarantees.
HTH's PE is in its fair range at 15x. On analysts' estimates for next year's earnings, today's price would be 16x, in its expensive range.
GS Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
GS has the edge over HTH on the outlook, with more favorable valuation and revenue expectations.
HTH Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| Low |
Analysts expect HTH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
GS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $72.35 | +4% |
| Q3 2026 | $69.58 | +41% |
| Q2 2026 | $64.82 | +43% |
| Q1 2026 | $54.75 | +27% |
| Q4 2025 | $51.32 | +27% |
| Q3 2025 | $49.22 | +44% |
| Q2 2025 | $45.37 | +45% |
| Q1 2025 | $43.08 | +68% |
| Q4 2024 | $40.54 | +77% |
GS has the edge over HTH on earnings, with more consistent year-over-year improvement.
HTH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.23 | -7% |
| Q3 2026 | $2.40 | -4.4% |
| Q2 2026 | $2.70 | +21% |
| Q1 2026 | $2.64 | +34% |
| Q4 2025 | $2.65 | +52% |
| Q3 2025 | $2.51 | +54% |
| Q2 2025 | $2.23 | +28% |
| Q1 2025 | $1.97 | +15% |
| Q4 2024 | $1.74 | +3% |
HTH's earnings per share have fallen from their peak: $2.40 over the past year, against $5.93 in early 2021.
GS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $18.7B | +23% |
| Q2 2026 | $20.3B | +39% |
| Q1 2026 | $17.2B | +14% |
| Q4 2025 | $13.5B | -3% |
| Q3 2025 | $15.2B | +20% |
| Q2 2025 | $14.6B | +15% |
| Q1 2025 | $15.1B | +6% |
| Q4 2024 | $13.9B | +23% |
GS has the edge over HTH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 37% | +2 points |
| Q2 2026 | 42% | +8.1 points |
| Q1 2026 | 38% | +0.2 points |
| Q4 2025 | 44% | +5.6 points |
| Q3 2025 | 36% | +4.1 points |
| Q2 2025 | 34% | +3.2 points |
| Q1 2025 | 37% | +0.6 points |
| Q4 2024 | 38% | +18 points |
GS has the edge over HTH on profitability, with a higher operating margin.
HTH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $309.5M | -6.3% |
| Q2 2026 | $315.8M | +4.1% |
| Q1 2026 | $300.5M | -5.6% |
| Q4 2025 | $329.9M | +9.6% |
| Q3 2025 | $330.2M | +8.1% |
| Q2 2025 | $303.3M | +2.1% |
| Q1 2025 | $318.5M | +12% |
| Q4 2024 | $301.1M | +3.7% |
HTH's revenue fell from its 2020 peak and has held roughly level since: $310M last quarter, down 6.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | -7 points |
| Q2 2026 | 16% | -0.5 points |
| Q1 2026 | 17% | -1.3 points |
| Q4 2025 | 16% | +1.4 points |
| Q3 2025 | 18% | +4.5 points |
| Q2 2025 | 16% | +6.4 points |
| Q1 2025 | 18% | +4.8 points |
| Q4 2024 | 15% | +1.5 points |
HTH's operating margin was 11% last quarter, down 7 points from the same quarter a year ago.
GS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +72% |
| Q2 2026 | $5.6B | +7.8% |
| Q1 2026 | -$32.4B | +$5.3B |
| Q4 2025 | -$16.8B | -136% |
| Q3 2025 | $2.1B | +$40.6B |
| Q2 2025 | $5.2B | -6.8% |
| Q1 2025 | -$37.7B | -$9.2B |
| Q4 2024 | $46.2B | +$75.1B |
GS's free cash flow was −$40B over the past year, against $15.8B the year before. Free cash flow isn't a meaningful measure for financial services companies like GS.
HTH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $503.6M | +86% |
| Q2 2026 | -$162.8M | +$71.7M |
| Q1 2026 | -$133.9M | -2757% |
| Q4 2025 | -$97M | -180% |
| Q3 2025 | $271M | -47% |
| Q2 2025 | -$234.6M | +$202.7M |
| Q1 2025 | $5M | -93% |
| Q4 2024 | $121.9M | -53% |
HTH has the edge over GS on cash generation, producing positive trailing cash flow while its opponent burns cash.
GS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -5.4x | Net Cash |
| Q2 2026 | -6.1x | Net Cash |
| Q1 2026 | -6.7x | Net Cash |
| Q4 2025 | -6.4x | Net Cash |
| Q3 2025 | -3.5x | Net Cash |
| Q2 2025 | -3.1x | Net Cash |
| Q1 2025 | -3.9x | Net Cash |
| Q4 2024 | -4.7x | Net Cash |
GS has the edge over HTH on leverage, with a lower net debt burden relative to earnings.
HTH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.9x | Net Cash |
| Q2 2026 | 2.2x | Moderate |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 2.7x | Moderate |
| Q3 2025 | -2.6x | Net Cash |
| Q2 2025 | -1.2x | Net Cash |
| Q1 2025 | -5.2x | Net Cash |
| Q4 2024 | 4.6x | High |
HTH has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like HTH.
GS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.5 | Neutral |
| Stochastic | 16.3 | Oversold |
GS's weekly RSI is 45 (neutral) and its Stochastic is 16 (oversold).
HTH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.6 | Neutral |
| Stochastic | 22.6 | Neutral |
HTH's weekly RSI is 42 (neutral) and its Stochastic is 23 (neutral).
GS PE vs Financial Services Sector
| Metric | GS | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 13x | 0.8% above |
| PE % | 46 | 63 | 17 pts below |
GS has the edge over HTH on valuation relative to its sector.
HTH PE vs Financial Services Sector
| Metric | HTH | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 16% above |
| PE % | 61 | 63 | 2 pts below |
HTH is trading at 15x earnings, a 16% premium to the Financial Services sector's median of 13x.
GS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $895.5 | 2% above |
| 20 week MA | $977.4 | 6.5% below |
| 50 week MA | $945.4 | 3.4% below |
| 100 week MA | $804.5 | 14% above |
| 200 week MA | $602.7 | 52% above |
GS has the edge over HTH on trend strength, trading above more of its moving averages.
HTH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $37.0 | 2.5% below |
| 20 week MA | $38.2 | 5.4% below |
| 50 week MA | $37.3 | 3.2% below |
| 100 week MA | $34.2 | 5.5% above |
| 200 week MA | $32.7 | 10% above |
HTH has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 10% above its 200-week average.
GS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $230.7 | $256.2 | +11% |
| 2021 | $256.2 | $385.0 | +50% |
| 2022 | $385.0 | $345.5 | -10% |
| 2023 | $345.5 | $385.8 | +12% |
| 2024 | $385.8 | $576.2 | +49% |
| 2025 | $576.2 | $907.0 | +57% |
| 2026 YTD | $907.0 | $913.6 | +0.7% |
GS has finished higher in five of the last six years, two of them by more than 50%. It's up 0.7% so far in 2026.
HTH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $24.6 | $27.3 | +11% |
| 2021 | $27.3 | $34.7 | +27% |
| 2022 | $34.7 | $29.7 | -14% |
| 2023 | $29.7 | $35.2 | +19% |
| 2024 | $35.2 | $28.9 | -18% |
| 2025 | $28.9 | $34.6 | +20% |
| 2026 YTD | $34.6 | $36.1 | +4.3% |
HTH has the edge over GS on returns for 2026, with the stronger performance.